Menu
Not yet recruiting NCT06862362

China Chronic Cough Registry: a Multicenter, Prospective, Observational Study

Observational Chronic Cough (CC)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Chronic Cough (CC). Basic parameters: 18 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

China Chronic Cough Cohort Study

Overview

The aim is to establish a national clinical database and biobanks for chronic coughers. Through real-world chronic cough case registry and follow-up studies, we will explore the clinical phenotypes and molecular subtypes of chronic cough.

Detailed description

There is currently no national cohort study on chronic cough in China. Preliminary researches indicated heterogeneity in the clinical phenotypes and hypersensitivity associated with chronic cough, highlighting the need to establish a large chronic cough cohort for further study. The completion of this project will provide real-world data for the management of chronic cough patients, contributing to the improvement of prevention, treatment, and management standards. It will also provide Chinese data for further refining cough guidelines. Additionally, by elucidating the phenotypes and molecular subtypes related to chronic cough, this study will be significant for identifying relevant targets to guide new drug development for chronic cough. This multicenter, prospective, observational study will enroll patients with chronic cough in a real-world clinic. Baseline information including demographics, cough characteristics, past treatment history, laboratory test results, initial diagnosis and treatment details will be recorded by using an online registration and follow-up platform. After the baseline data registration, we will conduct annual follow-ups for these patients over a period of two years. The cough prognosis and medication using history will be recorded at every follow-up. Some patients will provide biological samples such as sputum supernatant, serum, etc at baseline and follow-up. The diagnosis and treatment process for these patients is based on clinical practice/guideline standards, without any other interventions.

Primary outcome measures

  • Baseline demographics, clinical and pathophysiologic characteristics of the total patients in the chronic cough cohort [Time frame: After 6000 patients entry at baselin]
  • The prognosis of chronic cough in a real-word clinic [Time frame: From baseline to the end of follow-up at the second year]
  • Identifing phenotypes and endotypes, based on biomarkers and/or clinical parameters. [Time frame: After baseline entry and At the first or second year follow-up]

Eligibility criteria

Inclusion criteria

  • Is over 18 years old
  • Cough as the sole or main symptom
  • Has cough lasting more than 8 weeks
  • No obvious findings of Chest X-ray / Chest CT
  • Has no other evident diagnoses (e.g. IPF, NCFB, COPD, bronchiectasis, lung cancer)
  • Has given signed consent for inclusion in the study

Exclusion criteria

\-

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

China · 1 center
  • the First Affiliated Hospital of Guangzhou Medical University — Guangzhou

Identifiers

NCT: NCT06862362 · ES-2025-K005-01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗